Friday, July 07, 2017 6:39:39 AM
point of view, it was important to have a commercial deal in place prior to the ODAC
meeting otherwise a positive outcome would have strengthened even further OXB’s
already strong negotiating position.
. Forecasts suggest OXB will turn EBITDA
positive in 2017, and become profitable overall at the EBIT level in 2018.Bioprocessing
royalties are likely to result in significant upside potential in the near future.
Should CTL019 be approved,
OXB’s facilities would need another inspection by Novartis, adding to OXB’s
attractiveness as a clinical-grade vector manufacturer.
Our conservative estimate is that OXB will receive $82m in royalties by 2025
for CTL019 in B-ALL and DLBCL (including a lead-in period to include Health
Technology Assessments and other market access requirements). This does not take
into account bioprocessing revenues, or royalties from other CAR-T programmes.
Novartis CAR-T programmes
Candidate Target antigen *Indication Development
CTL019 CD19 B-ALL Pivotal phase II (ELIANA trial)
CTL019 CD19 DLBCL Pivotal phase II (JULIET trial)
BCMA MM Phase I/II
CTL119 CD19 CLL Human pilot
“CART22” CD22 B-ALL Terminated in phase I (June 2017)
Multiple Pre-clinical/phase I
HTTP://hardmanandco.com/docs/default-source/company-docs/oxford-biomedica-documents/07.07.17-major-deal-to-supply-novartis-car-t-programmes.pdf
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM